Anti-amyloid β activity of intravenous immunoglobulin (IVIG) in vitro
US8852874B2 · kind B2 · utility
2Cited by
1References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 25, 2009 |
| Grant date | Oct 7, 2014 |
| Priority date | — |
| Expiry date | Oct 17, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/10
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to a cell-based in vitro screening assay for identifying and selecting therapeutic agents that inhibit amyloid β-induced cytotoxicity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.